
Telwohn-M Tablet ER
Marketer
Riyadh Pharmaceutical
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Telwohn-M Tablet ER
Cardio-M Extended Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Prompt use improves heart attack survival rates. Consistent blood levels are achieved by taking Cardio-M ER with food daily, as directed by your physician. Continued use is crucial, even with symptom absence, as hypertension is often asymptomatic. Discontinuing treatment can worsen your condition. Lifestyle modifications, such as regular exercise, weight management, and a balanced diet, complement medication. Closely follow your doctor's instructions. Potential side effects include headache, fatigue, dizziness, low blood pressure, elevated potassium, occasional fainting (orthostatic hypotension), shortness of breath, nausea, vomiting, abdominal discomfort, and weakness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues before starting treatment. Pregnant or breastfeeding individuals should seek medical counsel before use. Always disclose all medications, particularly those for hypertension or heart conditions.
Primary Ingredients of Telwohn-M Tablet ER
No text was provided to rewrite.
Uses of Telwohn-M Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telwohn-M Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Telwohn-M Tablet ER with a meal.
Common Side effects of Telwohn-M Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telwohn-M Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Telwohn-M Tablet ER whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Telwohn-M Tablet ER works:
Telmisartan and Metoprolol Succinate are combined in the extended-release Telwohn-M Tablet to reduce blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telwohn-M Tablet ER and alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telwohn-M tablets present a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telwohn-M tablets appear to pose minimal breastfeeding risk. Available human data indicates negligible infant hazard.
DrivingUNSAFE
Taking Telwohn-M Extended-Release Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Telwohn-M Extended-Release tablets without any required dosage modification.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Telwohn-M Extended-Release tablets. Dosage modification for Telwohn-M Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Telwohn-M Tablet ER :
Should you forget a Telwohn-M Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telwohn-M Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
